Dashboard
Manage Tickers

VRTXVERTEX PHARMACEUTICALS INC ...

Nasdaq vrtx.com


$ 472.74 $ -1.49 (-0.31 %)    

Thursday, 27-Jun-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.07 $ 1.24 (0.26 %)
DIA $ 391.62 $ 0.32 (0.08 %)
SPY $ 546.37 $ 0.86 (0.16 %)
TLT $ 93.57 $ 0.37 (0.4 %)
GLD $ 215.08 $ 2.41 (1.13 %)
$ 472.51
$ 476.51
$ 0.00 x 0
$ 472.84 x 200
$ 472.04 - $ 477.70
$ 335.82 - $ 486.43
945,482
na
123.37B
$ 0.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 10-28-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-13-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 10-30-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 10-31-2016 09-30-2016 10-Q
32 08-01-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 02-16-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 07-31-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-vertex-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This Vertex Pharmaceuticals Analyst Begins...
06/27/2024 12:41:40

redburn-atlantic-initiates-coverage-on-vertex-pharmaceuticals-with-buy-rating-announces-price-target-of-545
Redburn Atlantic Initiates Coverage On Ver...
06/27/2024 09:46:51

Redburn Atlantic analyst Steve Chesney initiates coverage on Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy rating and anno...

peering-into-vertex-pharmaceuticalss-recent-short-interest
Peering Into Vertex Pharmaceuticals's Rece...
06/26/2024 20:30:19

wells-fargo-maintains-overweight-on-vertex-pharmaceuticals-raises-price-target-to-555
Wells Fargo Maintains Overweight on Vertex...
06/24/2024 13:01:44

Wells Fargo analyst Mohit Bansal maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price targe...

vertex-pharmaceuticals-presents-new-data-from-phase-12-clinical-trial-of-vx-880-stem-cell-derived-islet-cell-therapy-for-type-1-diabetes-updated-results-on-12-patients-show-consistency-with-previous-findings-and-highlight-transformative-potential
Vertex Pharmaceuticals Presents New Data F...
06/21/2024 19:46:04

– All 12 patients who received the full dose of VX-880 as a single infusion demonstrated islet cell engraftment and glucose-res...

heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-20-years
Here's How Much You Would Have Made Owning...
06/18/2024 19:30:29

13-analysts-have-this-to-say-about-vertex-pharmaceuticals
13 Analysts Have This To Say About Vertex ...
06/17/2024 18:00:16

argus-research-maintains-buy-on-vertex-pharmaceuticals-raises-price-target-to-550
Argus Research Maintains Buy on Vertex Pha...
06/17/2024 17:06:07

Argus Research analyst Jasper Hellweg maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target ...

nvidia-abbvie-vertex-pharmaceuticals-and-an-oil-giant-cnbcs-final-trades
Nvidia, AbbVie, Vertex Pharmaceuticals And...
06/17/2024 12:47:19

On CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals, Kevin Simpson named C...

Core News & Articles
CNBC Halftime Report Final Trades: NVIDIA,...
06/14/2024 17:00:47

vertex-reveals-long-term-data-on-casgevy-exagamglogene-autotemcel-at-eha-2024-congress
Vertex Reveals Long-Term Data On CASGEVY (...
06/14/2024 08:14:10

alphabet-to-rally-over-28-here-are-10-top-analyst-forecasts-for-tuesday
Alphabet To Rally Over 28%? Here Are 10 To...
06/11/2024 12:53:07

rbc-capital-maintains-sector-perform-on-vertex-pharmaceuticals-lowers-price-target-to-421
RBC Capital Maintains Sector Perform on Ve...
06/11/2024 11:36:19

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and lowers the price...

arcturus-inhaled-mrna-therapeutic-in-cystic-fibrosis-study-highlights-potential-amid-competitive-landscape-analyst
Arcturus' Inhaled mRNA Therapeutic In Cyst...
06/07/2024 18:44:44

Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, ...

vertex-to-present-new-data-demonstrating-significant-benefits-of-treatment-with-trikafta-at-the-ecfs-47th-european-cystic-fibrosis-conference-held-june-5-8-2024
Vertex To Present New Data Demonstrating S...
06/07/2024 16:03:01

- Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR m...

1000-invested-in-vertex-pharmaceuticals-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Vertex Pharmaceuticals 5...
06/05/2024 18:00:32

rbc-capital-reiterates-sector-perform-on-vertex-pharmaceuticals-maintains-424-price-target
RBC Capital Reiterates Sector Perform on V...
06/04/2024 13:50:18

RBC Capital analyst Brian Abrahams reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and maintains $424 ...

this-is-what-whales-are-betting-on-vertex-pharmaceuticals
This Is What Whales Are Betting On Vertex ...
06/03/2024 19:16:00

analyst-expectations-for-vertex-pharmaceuticalss-future
Analyst Expectations For Vertex Pharmaceut...
05/31/2024 15:01:19

bmo-capital-maintains-outperform-on-vertex-pharmaceuticals-raises-price-target-to-500
BMO Capital Maintains Outperform on Vertex...
05/31/2024 13:42:30

BMO Capital analyst Evan Seigerman maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and raises the price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)